Further studies utilizing this nonhuman primate model will provide insights into VEGFA-induced factors regulating aberrant ovarian angiogenesis contributing to development of ovarian hyperstimulation syndrome during COS cycles in women. The gene discussed is VEGFA; the disease is ovarian hyperstimulation syndrome.